Besins Healthcare has recently expanded its pharmaceutical operations through the acquisition of UniD Manufacturing, a Belgian company renowned for its expertise in long-acting drug delivery technologies. This strategic move aims to bolster Besins Healthcare's capabilities in developing advanced medical solutions.
The acquisition encompasses UniD's facility located in Seraing, Belgium, along with its 52 employees. These employees will transition to Besins Healthcare, where UniD Manufacturing will be rebranded as Besins Healthcare PharmTech. This new entity is set to become a dedicated center for future innovation and development projects, focusing on advanced polymer systems for complex drug delivery formats such as implants and vaginal rings. This integration is expected to significantly enhance the development of drug delivery systems that facilitate less frequent treatment administration.
This collaboration represents a natural partnership, bringing together two teams with extensive and complementary expertise. Both companies express excitement about the future prospects, envisioning continued innovation and service excellence for existing and new clients. While the financial details of the transaction remain undisclosed, UniD Manufacturing will maintain its current operations and client services in the immediate future, with Besins Healthcare continuing its global reach across 114 countries through its 22 subsidiaries, further solidifying its presence in the healthcare industry.
This acquisition marks a pivotal moment for Besins Healthcare, reinforcing its commitment to advancing patient care through innovative drug delivery solutions. By integrating UniD's specialized technologies, the company is poised to make significant strides in developing more effective and convenient treatment options, ultimately improving the quality of life for patients worldwide.
